At higher therapeutic doses, [[headache]], [[diarrhea]], [[dizziness]], [[dry mouth]], [[erectile dysfunction]], [[anxiety]], [[insomnia]], [[irritability]], [[lethargy]], and [[psychostimulant|{{abbr|CNS|central nervous system}} stimulation]] have been reported with fenfluramine.<ref name="Dart2004" />

 


 
There have been reports associating chronic fenfluramine treatment with [[emotional instability]], [[cognitive deficit]]s, [[depression (mood)|depression]], [[psychosis]], exacerbation of pre-existing psychosis ([[schizophrenia]]), and [[sleep disturbance]]s.<ref name="Dart2004" /><ref name="D.)Ahuja2005">{{cite book|author1=James O'Donnell (Pharm. D.)|author2=Gopi Doctor Ahuja|title=Drug Injury: Liability, Analysis, and Prevention|url=https://books.google.com/books?id=EB00rD8AqaYC&pg=PA276|year=2005|publisher=Lawyers & Judges Publishing Company|isbn=978-0-913875-27-8|pages=276–}}</ref> It has been suggested that some of these effects may be mediated by [[serotonergic]] [[neurotoxicity]]/depletion of serotonin with chronic administration and/or activation of serotonin [[5-HT2A receptor|5-HT<sub>2A</sub> receptor]]s.<ref name="D.)Ahuja2005" /><ref>{{cite book|title=Integrating the Neurobiology of Schizophrenia|url=https://books.google.com/books?id=mksAKriZXuYC&pg=PA142|date=27 February 2007|publisher=Academic Press|isbn=978-0-08-047508-0|pages=142–}}</ref><ref>{{cite book|title=The Pharmacology of Corticotropin-releasing Factor (CRF). Effects on Sensorimotor Gating in the Rat|url=https://books.google.com/books?id=kTADn_LMnZ4C&pg=PA12|year=2006|publisher=ProQuest|isbn=978-0-549-53661-1|pages=12–}}</ref><ref name="MullerJacobs2009">{{cite book|author1=Christian P. Muller|author2=Barry Jacobs|title=Handbook of the Behavioral Neurobiology of Serotonin|url=https://books.google.com/books?id=aomaKqIE1jUC&pg=PA630|date=30 December 2009|publisher=Academic Press|isbn=978-0-08-087817-1|pages=630–}}</ref>

 

